Erik de Vries

Erik de Vries is an accomplished professional in the field of biotechnology, currently serving as the Senior Business Development Director for Enzymes at BRAIN Biotech AG since June 2024. Concurrently, Erik de Vries has been the Chief Executive Officer of Enzymicals AG since November 2020, overseeing a significant Horizon 2020 EU project focused on enzymatic polymer degradation. With a strong background in biocatalysis, Erik de Vries has held various advisory and consulting roles, including positions at Allozymes and FabricNano, and founded Industrial Biotechnology Consulting to assist startups in the biotechnology sector. Erik de Vries' prior experience includes roles in business development at Dottikon Exclusive Synthesis AG and regional sales management at Amyris Inc., complemented by a Doctorate in Bioorganic Chemistry from the University of Groningen.